Matches in Nanopublications for { ?s ?p "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP602815.RAhktcxiQKXDjLYdacsRGrQrpukWDpIxVQIKQcwKHgWXQ130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602815.RAhktcxiQKXDjLYdacsRGrQrpukWDpIxVQIKQcwKHgWXQ130_provenance.
- NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160826.RAUWaoDe898z3TY1Idv0byTZl4qIfNnHe0pCAnTA-E-gw130_provenance.
- NP337669.RA3iVyTADDvtgA_klVW3P5JPdFQrFYcRtwOanb9FvXORk130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337669.RA3iVyTADDvtgA_klVW3P5JPdFQrFYcRtwOanb9FvXORk130_provenance.
- NP675526.RA_C7CnyXimqnorMf8fD5TUNzf5XRaovfn2grj03S_h_E130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675526.RA_C7CnyXimqnorMf8fD5TUNzf5XRaovfn2grj03S_h_E130_provenance.
- NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906972.RABvjxc_5eZ1G6kOrcd2lndJiKZT9f3bSCJqvq5f4KGzs130_provenance.
- NP637263.RAyeFQ7knEHdsx_Y_0bjhlb_s6nMBPGliiRfXx3gleAZ8130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637263.RAyeFQ7knEHdsx_Y_0bjhlb_s6nMBPGliiRfXx3gleAZ8130_provenance.
- NP906970.RA2dLaXGNTGBwHBtJJr2GoYh-eTi9QgbQ6ko3J8DiZpTw130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906970.RA2dLaXGNTGBwHBtJJr2GoYh-eTi9QgbQ6ko3J8DiZpTw130_provenance.
- NP906968.RAeZsrh8IsiPKNcDeUajxhpGt8APVm_aCtfxjh6_4Kcts130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906968.RAeZsrh8IsiPKNcDeUajxhpGt8APVm_aCtfxjh6_4Kcts130_provenance.
- NP637280.RAJNQlK1DkOJA1et66V8TlF0Lq2JuSk7GN4x5AjrVEhPc130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637280.RAJNQlK1DkOJA1et66V8TlF0Lq2JuSk7GN4x5AjrVEhPc130_provenance.
- NP906969.RAON18u7IuNBzsaQcYSQqi_u068whkmAufQsc26wOtCEI130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906969.RAON18u7IuNBzsaQcYSQqi_u068whkmAufQsc26wOtCEI130_provenance.
- NP636422.RAmaxO3viXRY3dO16ENlmx7PA3nWGfiXH_rOBOe2bu4JU130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636422.RAmaxO3viXRY3dO16ENlmx7PA3nWGfiXH_rOBOe2bu4JU130_provenance.
- NP636431.RAr59UYfvzSgcXaNOOG5AKkBqZi_ulC1Yn1iyd6LsmR80130_assertion description "[Both PPARα and PPARγ agonists are widely used in clinic for the treatment of hyperlipidemia and hyperglycemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636431.RAr59UYfvzSgcXaNOOG5AKkBqZi_ulC1Yn1iyd6LsmR80130_provenance.